|
|
Other links at Articles > Cardiology |
| 2. |
Prasugrel Submitted for Approval in US
|
|
|
- Daiichi Sankyo and Eli Lilly have submitted a new-drug application for the antiplatelet drug prasugrel to the US FDA for the treatment of ACS patients who are managed with PCI. If approved for marketing, the brand name will be Effient. Heartwire
|
|
|